within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01X_OtherAntibacterials.J01XX11_Tedizolid;
model Tedizolid 
   extends Pharmacolibrary.Drugs.ATC.J.J01XX11;

  annotation(Documentation(
    info ="<html><body><p>Tedizolid is an oxazolidinone-class antibacterial agent, primarily used for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). It is approved for use in adults and adolescents.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after administration of tedizolid phosphate 200 mg orally once daily.</p><h4>References</h4><ol><li><p>Tantalo, LC, et al., &amp; Mitjà, O (2023). Antimicrobial susceptibility of Treponema pallidum subspecies pallidum: an in-vitro study. <i>The Lancet. Microbe</i> 4(12) e994–e1004. DOI:<a href=&quot;https://doi.org/10.1016/S2666-5247(23)00219-7&quot;>10.1016/S2666-5247(23)00219-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37827185/&quot;>https://pubmed.ncbi.nlm.nih.gov/37827185</a></p></li><li><p>Bradley, JS, et al., &amp; Prokocimer, P (2016). Pharmacokinetics, Safety and Tolerability of Single Oral or Intravenous Administration of 200 mg Tedizolid Phosphate in Adolescents. <i>The Pediatric infectious disease journal</i> 35(6) 628–633. DOI:<a href=&quot;https://doi.org/10.1097/INF.0000000000001096&quot;>10.1097/INF.0000000000001096</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26910588/&quot;>https://pubmed.ncbi.nlm.nih.gov/26910588</a></p></li><li><p>Flanagan, S, et al., &amp; Prokocimer, P (2014). Pharmacokinetics of tedizolid in subjects with renal or hepatic impairment. <i>Antimicrobial agents and chemotherapy</i> 58(11) 6471–6476. DOI:<a href=&quot;https://doi.org/10.1128/AAC.03431-14&quot;>10.1128/AAC.03431-14</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25136024/&quot;>https://pubmed.ncbi.nlm.nih.gov/25136024</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Tedizolid;
